Press Release

Acute-on-Chronic Liver Failure Market to Exhibit Moderate Growth Rate During the Forecast Period (2022-2032), Investigates DelveInsight | Key Companies – Grifols Therapeutics, Versantis AG, HepaStem

The Acute-on-Chronic Liver Failure market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Acute-on-Chronic Liver Failure pipeline products

Read Full Article

80+ Active Companies working to develop 80+ Pipeline Therapies for Biliary Tract Cancers Treatment

DelveInsight’s, “Biliary Tract Cancers Pipeline Insight 2023” report provides comprehensive insights about 80+ companies and 80+ pipeline drugs in the Biliary Tract Cancers (BTCs) pipeline landscape. It covers the pipeline

Read Full Article

Triple Negative Breast Cancer Pipeline Assessment 2023| Insight into the current therapies, emerging drugs, treatment, outlook, and key companies: HiberCell, Roche, Infinity Pharmaceuticals, CytoDyn

DelveInsight Business Research LLP DelveInsight’s Triple Negative Breast Cancer Pipeline 2022, covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product

Read Full Article

KY Ent signs partnership with Samsung Electronics to bring K-POP karaoke to Smart TVs

Samsung Smart TV offers subscription ‘K-POP Keumyoung Karaoke” provided by KY Entertainment KY Entertainment, the leading Karaoke equipment & instrumental song supplier with 60% market share in South Korea market,

Read Full Article

Pulmonary Hypertension Clinical Trials | A Drug Pipeline Analysis Report 2023 | DelveInsight

DelveInsight Business Research LLP DelveInsight’s ‘Pulmonary Hypertension Pipeline Insight 2023’ report pipeline landscape. It covers the pipeline drug profiles, including

Read Full Article

Type 2 Diabetes Clinical Trial Pipeline Analysis | Insight into the Current Therapies, Emerging Drugs, Treatment, Outlook| Key Companies – Astrazenca, Hanmi Pharmaceuticals, and others

DelveInsight Business Research LLP DelveInsight’s Type 2 Diabetes Pipeline Insight, 2023, covers the pipeline drug profiles, including clinical and nonclinical

Read Full Article

100+ Active Companies working to develop 100+ Pipeline Therapies for Bladder Cancer Treatment

DelveInsight’s, “Bladder cancer Pipeline Insight 2023,” report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in the Bladder

Read Full Article

150+ Active Companies working to develop 150+ Pipeline Therapies for Colorectal Cancer Treatment

DelveInsight’s, “Colorectal Cancer Pipeline Insight 2023” report provides comprehensive insights about 150+ companies and 150+ pipeline drugs in the Colorectal

Read Full Article

140+ Active Companies working to develop 140+ Pipeline Therapies for Metastatic Colorectal Cancer Treatment

DelveInsight’s, “Metastatic Colorectal Cancer Pipeline Insight 2023,” report provides comprehensive insights about 140+ companies and 140+ pipeline drugs in the

Read Full Article

230+ Active Companies working to develop 230+ Pipeline Therapies for Gastric Cancer Treatment

DelveInsight’s, “Gastric Cancer Pipeline Insight 2023,” report provides comprehensive insights about 230+ companies and 230+ pipeline drugs in the Gastric

Read Full Article

Categories